IMPA1 and breast carcinoma: Therefore, we used those five target genes and IMPA1 as a gene set to investigate genomic variations by gene set variable analysis (GSVA) of breast cancer, and found that it was significantly higher in breast cancer (Figure S4H), especially in TNBC (Figure 6F), and significantly correlated with cell‐cycle pathway activity (Figure S4I).